<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Glanzer JG</submitter><funding>NCRR NIH HHS</funding><pagination>2589-95</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3399738</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(8)</volume><pubmed_abstract>The pharmacological suppression of the DNA damage response and DNA repair can increase the therapeutic indices of conventional chemotherapeutics. Replication Protein A (RPA), the major single-stranded DNA binding protein in eukaryotes, is required for DNA replication, DNA repair, DNA recombination, and DNA damage response signaling. Through the use of high-throughput screening of 1500 compounds, we have identified a small molecule inhibitor, 15-carboxy-13-isopropylatis-13-ene-17,18-dioic acid (NSC15520), that inhibited both the binding of Rad9-GST and p53-GST fusion proteins to the RPA N-terminal DNA binding domain (DBD), interactions that are essential for robust DNA damage signaling. NSC15520 competitively inhibited the binding of p53-GST peptide with an IC(50) of 10 μM. NSC15520 also in</pubmed_abstract><journal>Bioorganic &amp; medicinal chemistry</journal><pubmed_title>Small molecule inhibitor of the RPA70 N-terminal protein interaction domain discovered using in silico and in vitro methods.</pubmed_title><pmcid>PMC3399738</pmcid><funding_grant_id>P20 RR018759</funding_grant_id><funding_grant_id>P20-RR01875</funding_grant_id><pubmed_authors>Oakley GG</pubmed_authors><pubmed_authors>Glanzer JG</pubmed_authors><pubmed_authors>Liu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Small molecule inhibitor of the RPA70 N-terminal protein interaction domain discovered using in silico and in vitro methods.</name><description>The pharmacological suppression of the DNA damage response and DNA repair can increase the therapeutic indices of conventional chemotherapeutics. Replication Protein A (RPA), the major single-stranded DNA binding protein in eukaryotes, is required for DNA replication, DNA repair, DNA recombination, and DNA damage response signaling. Through the use of high-throughput screening of 1500 compounds, we have identified a small molecule inhibitor, 15-carboxy-13-isopropylatis-13-ene-17,18-dioic acid (NSC15520), that inhibited both the binding of Rad9-GST and p53-GST fusion proteins to the RPA N-terminal DNA binding domain (DBD), interactions that are essential for robust DNA damage signaling. NSC15520 competitively inhibited the binding of p53-GST peptide with an IC(50) of 10 μM. NSC15520 also in</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Apr</publication><modification>2026-04-29T06:50:09.996Z</modification><creation>2026-04-14T03:07:03.993Z</creation></dates><accession>S-EPMC3399738</accession><cross_references><pubmed>21459001</pubmed><doi>10.1016/j.bmc.2011.03.012</doi></cross_references></HashMap>